Open AccessCORRELATION BETWEEN PROLACTIN AND SYMPTOM PROFILE IN ACUTE ADMITTED WOMEN WITH RECURRENT SCHIZOPHRENIA
Author(s) -
Miroslav Herceg,
Krešimir Puljić,
Andrea Jambrošić Sakoman,
Jelena Sušac,
Ivana Todorić Laidlaw,
Dora Herceg,
Mirna Sisek-Šprem
Publication year - 2020
Publication title -
psychiatria danubina
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.394
H-Index - 34
eISSN - 1849-0867
pISSN - 0353-5053
DOI - 10.24869/psyd.2020.367
Subject(s) - neglect , psychological abuse , sexual abuse , psychology , feeling , psychopathology , child abuse , psychiatry , domestic violence , schizophrenia (object oriented programming) , physical abuse , social isolation , clinical psychology , borderline personality disorder , dysfunctional family , medicine , poison control , injury prevention , medical emergency , social psychology
The prevalence of hyperprolactinemia among psychiatric patients receiving antipsychotic medications was estimated to be between 30% and 70%. A review of the literature on prolactin and schizophrenia symptoms suggests that the correlation between them is complex and not limited to the adverse effects of antipsychotics. Relations with specific symptom dimensions have not been found consistently across studies. The association between increased prolactin and recurrent episodes of schizophrenia needs to be replicated in larger samples and in a population of female patients. The aim of this study was to find out whether elevated prolactin is related to specific symptoms or dimensions of schizophrenia, which is a heterogenic entity.